Individual Stock News
1. Contron (01912.HK) will see a change of controlling stake, with a takeover offer made at a discount of approximately 34.82%. Trading will resume on June 9.
2. SENASIC (06675.HK) will conduct its IPO from June 9 to June 12, planning to offer 53.407 million H shares globally.
3. CSPC Pharmaceutical Group (01093.HK): Smegglutide long-acting injection (SYH 9017) has received clinical trial approval in the United States.
4. Zhaoke Eye Hospital (06622.HK): The board of directors has approved a twelve-month share repurchase program with a total repurchase amount not exceeding HK$100 million.
5. Yuexiu Property (00123.HK): In May, the company achieved contracted sales (including contracted sales from joint ventures and associates) of approximately RMB11.303 billion, representing a year-on-year increase of approximately 18.0%, and contracted sales area of approximately 325,200 square meters, representing a year-on-year increase of approximately 33.0%.
6. Tencent Holdings (00700.HK): On June 8, Tencent repurchased 1.116 million shares on the Hong Kong Stock Exchange for approximately HKD 500 million.
7. Rongchang Biotechnology (09995.HK): The National Medical Products Administration conditionally approved the marketing application of Telitacicept Injection (RC18) for a new indication in the treatment of IgA nephropathy.
